Pharmaceuticals, Biotechnology and Life Sciences
MEDSIR, a leader in independent clinical research in oncology, strengthens its commitment to international collaboration and the exchange of scientific…
Company Records First Commercial Sale of revyve™ Wound GelWINNIPEG, Manitoba, Nov. 28, 2024 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-…
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 28, 2024 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13)…
The Company has received initial commitments totaling over $800,000 from strategic investors in connection with the OfferingVANCOUVER, British Columbia, Nov.…
FLORHAM PARK, N.J., Nov. 27, 2024 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative medicine company developing…
NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) — Applied Therapeutics, Inc. (Nasdaq: APLT), a biopharmaceutical company dedicated to creating transformative…
NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) — Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan”) today reported that it received a…
QIAGEN introduces market’s first customizable digital PCR assay design tool with advanced design algorithms tailored for diverse microbial applications and…
BOSTON, Nov. 27, 2024 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the…
REDWOOD CITY, Calif., Nov. 27, 2024 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted…